To design and synthesize novel triazoles, indazoles and aminopyridines from various
(thiophene-2-yl)prop-2-en-1-one derivatives as antitubercular leads by in silico and in vitro methods.
in silco Drug design, ADME prediction and molecular docking studies were performed to assess drug
likeliness and antitubercular potential of all 30 novel triazoles, indazoles and aminopyridines. in silico
Drug design studies revealed that the synthetic routes applied were appropriate according to the
calculations of Swiss-ADME that measure synthetic accessibility. Most of the synthesized compounds
found to have considerable binding score with enoyl ACP reductase enzyme of Mycobacterium
tuberculosis. All the synthesized compounds were evaluated for antitubercular potential against Drug
Resistant Mycobacterium tuberculosis H37Rv strain by Luciferase reporter assay method. Most of
the synthesized compounds exhibited remarkable antitubercular potential against resistant strain.